Meniere Disease Clinical Trial
Official title:
Diagnosing Endolymphatic Hydrops in Patients With Meniere Disease Using Magnetic Resonance Imaging With Intravenous Gadolinium Administration
Verified date | November 2016 |
Source | Emory University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | November 2016 |
Est. primary completion date | November 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of unilateral Meniere Disease (MD) per the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) - Glomerular filtration rate (GFR) > 90 mls/min/1.73 m2 - Creatinine (Cr) level serum < 1.6 mg/dl Exclusion Criteria: - Age < 18 years - Diagnosis of bilateral MD - History of prior temporal bone surgery - History of cochlear implant placement - Pacemaker, cardiac implantable electronic device, shrapnel, aneurysm clips or other metal objects that are prohibited in the MR suite - GFR < 90 mls/min/1.73m2 - Cr level > 1.6 mg/d - Lack of IV access - Contrast allergy to gadolinium agent - Pregnancy - Claustrophobia necessitating parenteral anxiolytics - Patients who are unable to provide informed consent for themselves |
Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
United States | Emory University Department of Otolaryngology Clinic | Atlanta | Georgia |
Lead Sponsor | Collaborator |
---|---|
Emory University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Grade of endolymphatic hydrops (EH) in the cochlea and vestibule | Two Certificate of Added Qualifications (CAQ)-certified neuroradiologists will evaluate the MRI findings. The degree of EH in the vestibule and cochlea will be classified as "none", "grade I" and "grade II," with grade I being defined as mild and grade II being defined as significant. | 6 hours after intravenous contrast injection | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04835688 -
Ventilation Tube Insertion for Unilateral Menière's Disease
|
N/A | |
Recruiting |
NCT05851508 -
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
|
Phase 3 | |
Not yet recruiting |
NCT05322538 -
Menier's Disease - Bone Density Study
|
N/A | |
Completed |
NCT05328895 -
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
|
N/A | |
Completed |
NCT04569175 -
Non Enhanced Labyrinth Imaging for the Detection of Endolymphatic Hydrops in Meniere's Disease "NELI Study"
|
N/A | |
Not yet recruiting |
NCT05582148 -
Meniere Disease and Hearing Aids
|
N/A | |
Completed |
NCT05844657 -
Comprehensive Evaluation in Patients With Meniere's Disease
|
||
Completed |
NCT04902963 -
What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube?
|
N/A | |
Completed |
NCT04686695 -
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
|
N/A | |
Recruiting |
NCT04815187 -
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
|
Phase 4 | |
Recruiting |
NCT06278129 -
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
|
||
Recruiting |
NCT04766853 -
Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss
|
Phase 1/Phase 2 | |
Recruiting |
NCT04370366 -
Imaging of Endolymphatic Hydrops at 7T MRI
|
||
Enrolling by invitation |
NCT03520322 -
A Study of a Mastoid Device in Subjects With Ménière's Disease
|
N/A | |
Withdrawn |
NCT04674735 -
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
|
Phase 1 | |
Not yet recruiting |
NCT05424302 -
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
|
N/A | |
Recruiting |
NCT03795675 -
CI Following VS Removal or Labyrinthectomy
|
N/A | |
Completed |
NCT04218123 -
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
|
Phase 2/Phase 3 | |
Completed |
NCT05960786 -
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
|
N/A | |
Terminated |
NCT02529475 -
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
|
Phase 4 |